AGP Picks
View all

Middle East Tech Today: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Middle East Tech Today.

Press releases published on July 1, 2026

ORYZON Raises €12 Million and Signs a Financing Agreement with COFIDES to Strengthen its Balance Sheet and Accelerate its Clinical Programs
Correction: Abivax Announces Pricing of Highly Oversubscribed and Upsized $800M (€702M) Public Offering of American Depositary Shares
Correction: Abivax annonce la fixation du prix de l’Offre au public largement sursouscrite de 800 M$ (702 M€) d’American Depositary Shares
Sana Biotechnology Announces Symposium Presentation at the European Association for the Study of Diabetes (EASD) Annual Meeting 2026
Bit Origin Announces Balance Sheet Strengthening Following Strategic AI Infrastructure Acquisition
ibex Honors the Winners of the 5th Annual CX Leadership Awards at CCW Las Vegas
Creative Medical Technology Holdings Issues Mid-Year Update
Cuentas Executives Double Down on the Company’s Future with Open-Market Stock Purchases
Türkiye’s leading digital asset platform Paribu expands its platform into DeFi, yield, and equities
Berto Acquisition Corp. II Announces the Separate Trading of its Ordinary Shares and Warrants, Commencing on or about July 6, 2026
MathCo Expands Databricks Center of Excellence to Help Retail and CPG Enterprises Operationalize Agentic AI
Amoéba has received marketing authorization in France for its biofungicide AXPERA
Amoéba obtient l’autorisation de mise sur le marché en France pour son biofongicide AXPERA
Amoéba verkrijgt in Frankrijk een vergunning voor het in de handel brengen van zijn biofungicide AXPERA
Amoéba obtém autorização de colocação no mercado em França para o seu biofungicida AXPERA
Amoéba obtiene la autorización de comercialización en Francia para su biofungicida AXPERA
Amoéba ottiene l’autorizzazione all'immissione in commercio in Francia per il suo biofungicida AXPERA
Abivax announces trading resumption of its ordinary shares on Euronext Paris
Abivax annonce la reprise des négociations de ses actions ordinaires sur Euronext Paris
SERB Pharmaceuticals Completes Acquisition of European and MENA Rights to Idefirix® (imlifidase) from Hansa Biopharma

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Middle East Tech Today

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.